Creative Biolabs Expands Single-Cell Multi-Omics Solutions

SHIRLEY, NY, September 09, 2026 /CourierPR/ -- Creative Biolabs has expanded its suite of advanced single-cell multi-omics and RNA sequencing solutions to support biomedical research, addressing the growing need for high-resolution cellular profiling.

As life science research transitions from bulk tissue analysis to single-cell resolution, dissecting cellular heterogeneity has become essential for identifying rare cell subpopulations, characterizing complex tumor microenvironments, and tracing cell lineage trajectories. Creative Biolabs aims to support these critical pipelines by delivering robust, high-throughput single-cell RNA sequencing services that offer high sensitivity and coverage across thousands of individual cells, providing high-resolution transcriptomic insights from diverse fresh biological specimens.

The company has also developed specialized single-nucleus RNA sequencing (snRNA-seq) capabilities to address the long-standing challenge of processing complex, fibrous, or biobanked archival samples. For tissues such as human brain, myocardium, or flash-frozen clinical biopsies, where single-cell dissociation can result in cell damage, dissociation-induced stress responses, or selective loss of fragile cell types, Creative Biolabs provides an optimized single-cell nuclei RNA sequencing service. By isolating intact nuclei, this approach bypasses harsh enzymatic dissociation while minimizing dissociation-related artifacts, retaining informative nuclear RNA profiles and dramatically expanding the scope of clinical translational research.

Beyond single-dimensional analysis, Creative Biolabs has advanced its high-throughput single-cell multi-omics service. This integrated platform allows the simultaneous interrogation of genomic variations, epigenomic landscapes (such as chromatin accessibility), cell surface proteomics (CITE-seq), and transcriptomes within identical single cells. By directly linking epigenetic regulation and genomic alterations to gene expression readouts, the service enables researchers to construct multi-dimensional cellular atlases and uncover novel therapeutic targets with unprecedented biological clarity.

"Understanding biology at single-cell and single-nucleus resolution is no longer a luxury, it is fundamental to precision medicine and biomarker discovery," said a senior scientist at Creative Biolabs. "Our goal is to provide researchers with a seamless, modular analytical ecosystem that transforms difficult biological samples into reliable, high-dimensional datasets with rigorous bioinformatics support."

Creative Biolabs utilizes advanced microfluidics technologies, stringent quality control benchmarks, and tailored bioinformatics pipelines to support academic and biopharmaceutical research teams worldwide. The company is dedicated to providing cutting-edge single-cell technologies, next-generation sequencing, and comprehensive multi-omics solutions, supporting discovery programs in target validation, immunology profiling, and translational drug development.